Skip to main content
Resource Center

What Is Trial Intelligence?

8 min readBest For Clinical Operations

Trial Intelligence is the category that turns a protocol into traceable clinical intelligence with operational follow-through. It is what comes after protocol search and after AI-generated text, and what comes before regulated clinical execution.

What Trial Intelligence is.

Trial Intelligence is the structured, sourced, and versioned understanding of everything a protocol implies for study execution, regulatory success, and submission readiness. It is produced by an engine, not by a person reading a PDF, and it is consumed by operators, not just executives.

Working Definition

Trial Intelligence is the structured, sourced, versioned understanding of a clinical protocol that drives execution, evidence generation, submission readiness, and inspection.

The Trial Intelligence Brief is the first expression of Trial Intelligence. It is not the destination. It is where the operating system begins. The same underlying intelligence drives execution, evidence accumulation, submission readiness, and inspection preparation.

Trial Intelligence extends beyond what protocol search was designed to do, and beyond what AI assistants are designed to produce.

What Trial Intelligence is not.

Three adjacent categories get confused with Trial Intelligence. Each is real, each is useful, and none of them is what PrismCDM produces.

Protocol Search

Search returns matching protocols. It does not produce a sourced conclusion about a single protocol. It tells you what exists, not what to do.

Generic AI

An assistant answers questions. It does not preserve provenance, drive operational workflows, or accumulate inspection-ready evidence. Useful for exploration, not for submission.

Clinical Data Management

A clinical data management platform captures the data a study generates. It does not generate intelligence about the protocol itself before execution begins.

Trial Intelligence sits upstream of clinical data management, downstream of search, and outside the boundary of what an AI assistant is designed to do.

Why this matters: the operating-system view of clinical development.

Clinical development is currently composed of specialized systems coordinated through manual handoffs, spreadsheets, and institutional knowledge. Trial Intelligence is the substrate that turns those specialized systems into a coherent operating system. The same intelligence that produces a Brief drives the execution workspace, the accumulating evidence package, and the submission readiness scorecard.

This is the architectural difference. An AI assistant produces answers. A Trial Intelligence engine produces a continuously reusable layer of intelligence that every downstream workflow can consume.

Who uses Trial Intelligence first

Executive review, protocol team, regulatory leadership. Read the Brief and the PTII™ composite to evaluate readiness and prioritize amendments.

Who benefits next

The execution workspace, the evidence platform, the submission readiness scorecard, and the inspection evidence package. All driven by the same intelligence.

One substrate. End to end.

The same intelligence flows through every downstream stage of the study. Nothing is regenerated for each stage. Nothing is re-interpreted. The same conclusions that scored the protocol inform the operational workspace that runs the study and the inspection package that closes it.

  1. Protocol
  2. Trial Intelligence
  3. Execution
  4. Evidence
  5. Submission
  6. Inspection
From reading to verifying

See Trial Intelligence on one of your protocols.

Generate a Brief from a public NCT identifier, or bring one of your own protocols for a guided Strategy Session.